AI ScreeningAI ChatPricing
  1. JP-listed companies
  2. LTT Bio-Pharma Co., Ltd.
  3. Financials
  4. Total non-current assets

LTT Bio-Pharma Co., Ltd.【JP:E00982】

Market cap
P/E ratio
SummaryFinancialsDividendsHistoryWorkforce
Period EndTotal non-current assets (Million JPY)YoY (%)
Mar 31, 20251,379-0.87%
Mar 31, 20241,391+31.75%
Mar 31, 20231,056+8.07%
Mar 31, 2022977-22.94%
Mar 31, 20211,268-18.78%
Mar 31, 20201,562+1.40%
Mar 31, 20191,540+132.80%
Mar 31, 2018662+84.14%
Mar 31, 2017359+472.20%
Mar 31, 201663-11.36%
Mar 31, 201571

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)